Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

October 31, 2009

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene

All Subjects will treat the face once daily in the evening.

BEHAVIORAL

frequent visits

This group will be asked to return to the study center on weeks 1, 2, 4 and 8 for office visits (to remind the Subject to apply the study medication); in addition to the study visits on Weeks 6 and 12.

BEHAVIORAL

electronic reminder

This group will receive a daily electronic reminder by email, text pager, or phone message (approximately at the same time each day) to use the study medication within a 4-hour window after the reminder and will return to the study center for study visits on Weeks 6 and 12.

BEHAVIORAL

Parent reminder

In this group parents will be prompted by a daily electronic message by email, text pager, or phone message (approximately at the same time each day) to remind the Subject to use the study medication within a 4-hour window after the reminder. Parents will be instructed to then verbally deliver the message to the study Subject. Subjects will return to the study center for study visits on Weeks 6 and 12.

BEHAVIORAL

Standard of care

"This group is considered to be the standard of care arm and will return to the study center for study visits on Weeks 6 and 12. This group will not receive any kind of reminders other than the instructions provided by the study staff during the study visits."

Trial Locations (1)

27157

Wake Forest University Health Sciences Dermatology, Winston-Salem

All Listed Sponsors
lead

Wake Forest University

OTHER

NCT00696449 - Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris | Biotech Hunter | Biotech Hunter